Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Comparing two doses of corticosteroids for frozen shoulder treatment

Official title: Dose Comparison for the Treatment of Adhesive Capsulitis with Hydrodilatation and Corticosteroid Using an Anterior Approach Under Ultrasound-Guidance

Run by University Health Network, Toronto · NCT06848374 · Data updated 2026-11-12

This study is testing whether two different doses of a steroid injection can help people with frozen shoulder feel less pain and move their shoulder better.

More Adhesive Capsulitis trials

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity Health Network, Toronto
Academic / other
Locations1 site (Toronto, Ontario)
StatusRecruiting
StartedDecember 20, 2024
Main results expectedJune 30, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 27, 2025
Trial IDNCT06848374 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old diagnosed with adhesive capsulitis of the shoulder.

Probably not a fit

Patients who have received an injection in the affected shoulder within the last three months or have a history of shoulder surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the efficacy of two different doses of methylprednisolone (40 mg vs 80 mg) combined with hydrodilatation in treating adhesive capsulitis of the shoulder. The study will enroll 40 participants who will be randomly assigned to receive one of the two doses during an ultrasound-guided procedure. Pain reduction, shoulder mobility improvement, and side effects will be assessed through various questionnaires and measurements at baseline and four weeks post-treatment. The trial is designed as a double-blind study to ensure unbiased results.

Why it matters

Potential benefit: If successful, this study could provide insights into optimal corticosteroid dosing for improved pain relief and mobility in patients with frozen shoulder.

How similar studies have gone: Previous studies have shown varying success with corticosteroid treatments for adhesive capsulitis, but this specific dose comparison is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* \>18 years of age
* Diagnostic of adhesive capsulitis of the shoulder

Exclusion Criteria:

* Injection received in the affected shoulder \< 3 months ago (any kind)
* History of previous surgery in the affected shoulder
* Glenohumeral osteoarthritis more than mild on the xray
* Pregnancy
* Blood thinner (other than Aspirin 80 mg) or bleeding disorder
* Active infection (requiring antibiotic)
* Allergy to steroid or lidocaine
* Cognitive impairment
* Active litigation
* Inflammatory connective tissue disorder

Where it's running

  • Toronto Rehabilitation Institution
    Toronto, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.